Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
UBS
Fish and Richardson
Healthtrust
Dow
McKinsey
AstraZeneca
Medtronic
Cerilliant

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,084,479

« Back to Dashboard

Summary for Patent: 5,084,479
Title: Novel methods for treating neurodegenerative diseases
Abstract:The instant invention is novel uses of known cyclic amino acids. Such compounds as gabapentin are used for treating neurodegenerative disorders, perinatal asphyxia, status epilepticus, Alzheimer's Hungington's, Parkinson's, and Amyotrophic Lateral Sclerosis.
Inventor(s): Woodruff; Geoffrey N. (Herts, GB)
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Application Number:07/615,151
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 5,084,479

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,084,479

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 125701 ➤ Try a Free Trial
Germany 69111642 ➤ Try a Free Trial
Denmark 0446570 ➤ Try a Free Trial
European Patent Office 0446570 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Fuji
Colorcon
Baxter
Chubb
QuintilesIMS
Dow
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.